Wong and Cox have demonstrated the activity of Aureomycin against the viruses of the psittacosis-lymphogranuloma venereum group in experimental animals (1) . Clinical accounts of the effectiveness of Aureomycin in the treatment of conditions such as eczema vaccinatum (vaccinial infection superimposed on a pre-existing eczema) have been reported (2) . Terramycin has been reported to be effective against the PR8 strain of influenza A in the chick embryo by Vinson and Walsh (3) and a recent report details its potency in the treatment of primary atypical pneumonia (4). The present experiment was undertaken to evaluate critically the effects of these drugs on the vaccinia virus in the embryonated egg.
METHOD AND MATERIALS
The drugs were dissolved in normal saline. Injections at the dosage levels shown in Tables I and II were made into the yolk sac of the 10 day old embryo. After allowing one hour for dispersion of the drug throughout the embryonic tissues the eggs were prepared by the false air sac technic (5) and the virus inoculated onto the chorioallantoic membrane. Normal saline was the drug control. The vaccinia used in these experiments was egg adapted by thirty passages on the chorioallantoic membrane. The effects of the drugs on virus multi-plication could be determined quite accurately by counting the plaques on the CAM after 48 hours incubation. Each plaque was considered to be the point of propagation of one infectious unit of virus. In other respects the method was that described in a previous report (6) .
RESULTS
The in vivo effects of Aureomycin and Terramycin on vaccinia are shown in Tables I and   II , respectively. It is apparent that at all dosage levels and at even the highest virus dilutions these drugs were ineffective in reducing the viability of the virus below that of the controls.
CONCLUSIONS
Under the conditions of this experiment, Aureomycin and Terramycin have been shown to have no demonstrable activity aginst the vaccinia virus as measured in the embryonated egg.
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